About Riconpharma India Private Limited
Data last updated:
Riconpharma India Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Riconpharma Llc. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2009PTC062946. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹4.83 Cr. It is led by directors including Valiveti Brahmaji and Mukteeshwar Gande.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground 1st 2nd Floors At Plot No – 5C Ida Uppal, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.3 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹88.12 Lakh (net margin 3.2%) and EBITDA of ₹4.13 Cr (EBITDA margin 15.1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 3% over five years.
The company has about 87 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: RiconPharma. As per MCA filings, the company has open charges of ₹55.17 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website riconpharma.com.
Company details
CIN history
Riconpharma India has one previous CIN (Corporate Identification Number): U24232AP2009PTC062946. The current CIN is U24232TG2009PTC062946, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2009PTC062946 | Current |
| U24232AP2009PTC062946 | Previous |
Contact details
Riconpharma India Private Limited's registered office is in Hyderabad, Telangana. Its website is riconpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGround 1st 2nd Floors At Plot No – 5C Ida Uppal, Hyderabad, Telangana, India – 500039
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Riconpharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Riconpharma India operates one associated brand: RiconPharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A CRO specializing in novel drug formulations and delivery systems. | riconpharma.com |
Business activity
The main business activity of Riconpharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Riconpharma India Private Limited, buy the company report.
Financials of Riconpharma India Private Limited
FY 2025 filings availableRiconpharma India Private Limited reported revenue of ₹27.3 Cr (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 24% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹88.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.1% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Riconpharma India Private Limited, buy the company report.
Board of directors of Riconpharma India Private Limited
Riconpharma India has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Valiveti Brahmaji Also directs: Prathyak Laboratories Private Limited, Vivint Pharma Private Limited, Difgen Pharmaceuticals Private Limited and 2 more | Director | 01 Oct 2014 | 12 Years 0 Months | Current |
| Mukteeshwar Gande | Director | 12 Feb 2015 | 11 Years 8 Months | Current |
| Nageswara Rao Muntha Venkata | Director | 23 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Riconpharma India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Augxen Pharma Private Limited | ₹27.52 Cr (FY 2025) | 134.0% | Bharuch, Gujarat, India | |||
| Cirex Pharmaceuticals Private Limited | ₹27.51 Cr (FY 2025) | 487.0% | Hyderabad, Telangana, India | |||
| Acme Diet Care Private Limited | ₹27.35 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India | |||
| Riconpharma India Private Limitedthis company | ₹27.3 Cr (FY 2024) | ₹88.12 Lakh | 3.2% | 24.0% | 87 | Hyderabad, Telangana, India |
| Sun Moon Pharmaceuticals Private Limited | ₹27.19 Cr (FY 2025) | 48.0% | Boisar, Maharashtra, India |
To see the full peer comparison of Riconpharma India Private Limited, buy the company report.
Auditor
Riconpharma India Private Limited is audited by GUDURU SREENIVASA RAO AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUDURU SREENIVASA RAO AND CO | FY 2023 | 025329S |
Shareholding
The shareholding of Riconpharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Riconpharma India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Oct 2024 | 101037384 | Hdfc Bank Limited | ₹55.17 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Riconpharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riconpharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Riconpharma India Private Limited has a workforce of 87 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Riconpharma India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Riconpharma India Private Limited, buy the company report.
Recent activity
Riconpharma India Private Limited has 8 board changes on record since 2014: 3 appointments and 5 cessations. The latest: Develpalli Shailesh Kumar ceased to be Director on 22 Mar 2019.
Frequently asked questions
Riconpharma India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 March 2009 (17+ years old) and is registered under CIN U24232TG2009PTC062946.
Riconpharma India has 3 current directors:
- Valiveti Brahmaji - Director
- Mukteeshwar Gande - Director
- Nageswara Rao Muntha Venkata - Director
The latest financial statements of Riconpharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Riconpharma India has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Riconpharma India is U24232TG2009PTC062946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riconpharma India was incorporated on 03 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Riconpharma India by revenue are Augxen Pharma Private Limited, Cirex Pharmaceuticals Private Limited, Acme Diet Care Private Limited, Sun Moon Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Develpalli Shailesh Kumar ceased to be Director on 22 Mar 2019. Nageswara Rao Muntha Venkata was appointed as Director on 23 Jan 2018. Satyanaryana Valiveti ceased to be Additional Director on 30 Sep 2015. Riconpharma India has 8 board changes on record in total.
Riconpharma India can be reached through the website riconpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Riconpharma India is at Ground 1st 2nd Floors At Plot No – 5C Ida Uppal, Hyderabad, Telangana, India – 500039.
Riconpharma India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
